{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:40:04Z","timestamp":1753893604739,"version":"3.41.2"},"reference-count":35,"publisher":"Sociedade Brasileira de Cardiologia","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,4]]},"DOI":"10.36660\/abc.20230004","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T15:16:29Z","timestamp":1693926989000},"source":"Crossref","is-referenced-by-count":1,"title":["Escores de Risco Cardiovascular entre Adultos Assintom\u00e1ticos com Hemofilia"],"prefix":"10.36660","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9025-0289","authenticated-orcid":false,"given":"Ricardo Mesquita","family":"Camelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-5684","authenticated-orcid":false,"given":"Camila","family":"Caram-Deelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7930-3316","authenticated-orcid":false,"given":"Bruna Pontes","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4270-0545","authenticated-orcid":false,"given":"Marilia Carolina Braga de","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3048-4408","authenticated-orcid":false,"given":"Neuza Cavalcanti de Moraes","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5556-6122","authenticated-orcid":false,"given":"Iris Maciel","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria","family":"Vanderlei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6950-2015","authenticated-orcid":false,"given":"Tania Maria Rocha","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1957-4122","authenticated-orcid":false,"given":"Samantha","family":"Gouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3083-7093","authenticated-orcid":false,"given":"Suely Meireles","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9095-2475","authenticated-orcid":false,"given":"Johanna van der","family":"Bom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"key":"key20230905111604_B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","unstructured":"1. Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe SW, et al. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 2020;26(Suppl 6):1-158. doi: 10.1111\/hae.14046.","journal-title":"Haemophilia"},{"key":"key20230905111604_B2","volume-title":"Report on the Annual Global Survey 2020","author":"World Federation of Haemophilia","year":"2020","unstructured":"2. World Federation of Haemophilia. Report on the Annual Global Survey 2020 [Internet]. Montr\u00e9al: WFH; 2020 [cited 2023 Aug 17]. Available from: https:\/\/www1.wfh.org\/publications\/files\/pdf-2045.Pdf."},{"issue":"4","key":"key20230905111604_B3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2141.1985.tb07353.x","article-title":"Life Expectancy of Swedish haemophiliacs, 1831-1980","volume":"59","author":"Larsson","year":"1985","unstructured":"3. Larsson SA. Life Expectancy of Swedish haemophiliacs, 1831-1980. Br J Haematol. 1985;59(4):593-602. doi: 10.1111\/j.1365-2141.1985.tb07353.x.","journal-title":"Br J Haematol"},{"issue":"3","key":"key20230905111604_B4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2516.2009.02188.x","article-title":"Mortality and Causes of Death in Italian Persons with Haemophilia, 1990-2007","volume":"16","author":"Tagliaferri","year":"2010","unstructured":"4. Tagliaferri A, Rivolta GF, Iorio A, Oliovecchio E, Mancuso ME, Morfini M, et al. Mortality and Causes of Death in Italian Persons with Haemophilia, 1990-2007. Haemophilia. 2010;16(3):437-46. doi: 10.1111\/j.1365-2516.2009.02188.x.","journal-title":"Haemophilia"},{"issue":"3","key":"key20230905111604_B5","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1111\/hae.13730","article-title":"Mortality of Patients with Haemophilia in Brazil: First Report","volume":"25","author":"Jardim","year":"2019","unstructured":"5. Jardim LL, van der Bom JG, Caram-Deelder C, Gouw SC, Cherchiglia ML, Rezende SM. Mortality of Patients with Haemophilia in Brazil: First Report. Haemophilia. 2019;25(3):e146-e152. doi: 10.1111\/hae.13730.","journal-title":"Haemophilia"},{"issue":"5","key":"key20230905111604_B6","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","article-title":"2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"152","author":"Levine","year":"2016","unstructured":"6. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016;152(5):1243-75. doi: 10.1016\/j.jtcvs.2016.07.044.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"key20230905111604_B7","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","unstructured":"7. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344-e418. doi: 10.1161\/STR.0000000000000211.","journal-title":"Stroke"},{"issue":"6","key":"key20230905111604_B8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/hae.12189","article-title":"Applicability of the European Society of Cardiology Guidelines on Management of Acute Coronary Syndromes to People with Haemophilia - An Assessment by the ADVANCE Working Group","volume":"19","author":"Staritz","year":"2013","unstructured":"8. Staritz P, Moerloose P, Schutgens R, Dolan G; ADVANCE Working Group. Applicability of the European Society of Cardiology Guidelines on Management of Acute Coronary Syndromes to People with Haemophilia - An Assessment by the ADVANCE Working Group. Haemophilia. 2013;19(6):833-40. doi: 10.1111\/hae.12189.","journal-title":"Haemophilia"},{"issue":"2","key":"key20230905111604_B9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/CRD.0000000000000045","article-title":"Consensus Review of the Treatment of Cardiovascular Disease in People with Hemophilia A and B","volume":"23","author":"Ferraris","year":"2015","unstructured":"9. Ferraris VA, Boral LI, Cohen AJ, Smyth SS, White GC 2nd. Consensus Review of the Treatment of Cardiovascular Disease in People with Hemophilia A and B. Cardiol Rev. 2015;23(2):53-68. doi: 10.1097\/CRD.0000000000000045.","journal-title":"Cardiol Rev"},{"key":"key20230905111604_B10","volume-title":"Perfil das Coagulopatias Heredit\u00e1rias","author":"Brasil","year":"2016","unstructured":"10. Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Departamento de Aten\u00e7\u00e3o Especializada e Tem\u00e1tica. Perfil das Coagulopatias Heredit\u00e1rias. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2016."},{"issue":"25","key":"key20230905111604_B11","first-page":"S49","article-title":"2013 ACC\/AHA Guideline on the Assessment of Cardiovascular Risk: a Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","unstructured":"11. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R, et al. 2013 ACC\/AHA Guideline on the Assessment of Cardiovascular Risk: a Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49-73. doi: 10.1161\/01.cir.0000437741.48606.98.","journal-title":"Circulation"},{"issue":"5","key":"key20230905111604_B12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cjca.2015.02.001","article-title":"The New Pooled Cohort Equations Risk Calculator","volume":"31","author":"Preiss","year":"2015","unstructured":"12. Preiss D, Kristensen SL. The New Pooled Cohort Equations Risk Calculator. Can J Cardiol. 2015;31(5):613-9. doi: 10.1016\/j.cjca.2015.02.001.","journal-title":"Can J Cardiol"},{"issue":"19","key":"key20230905111604_B13","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","unstructured":"13. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Himmelfarb CD, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248. doi: 10.1016\/j.jacc.2017.11.006.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"key20230905111604_B14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/M15-3016","article-title":"Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes","volume":"164","author":"Chamberlain","year":"2016","unstructured":"14. Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, Neuman A. Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med. 2016;164(8):542-52. doi: 10.7326\/M15-3016.","journal-title":"Ann Intern Med"},{"key":"key20230905111604_B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease","volume":"23","author":"Jellinger","year":"2017","unstructured":"15. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease. Endocr Pract. 2017;23(Suppl 2):1-87. doi: 10.4158\/EP171764.APPGL.","journal-title":"Endocr Pract"},{"issue":"17","key":"key20230905111604_B16","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and Management of the Metabolic Syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","unstructured":"16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735-52. doi: 10.1161\/CIRCULATIONAHA.105.169404.","journal-title":"Circulation"},{"issue":"6","key":"key20230905111604_B17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","unstructured":"17. D\u2019Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study. Circulation. 2008;117(6):743-53. doi: 10.1161\/CIRCULATIONAHA.107.699579.","journal-title":"Circulation"},{"issue":"25","key":"key20230905111604_B18","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.jacc.2010.09.001","article-title":"2010 ACCF\/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"56","author":"Greenland","year":"2010","unstructured":"18. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF\/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56(25):e50-103. doi: 10.1016\/j.jacc.2010.09.001.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"key20230905111604_B19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1160\/TH10-07-0460","article-title":"Cardiovascular Risk Assessment in Haemophilia Patients","volume":"105","author":"Biere-Rafi","year":"2011","unstructured":"19. Biere-Rafi S, Baarslag MA, Peters M, Kruip MJ, Kraaijenhagen RA, den Heijer M, et al. Cardiovascular Risk Assessment in Haemophilia Patients. Thromb Haemost. 2011;105(2):274-8. doi: 10.1160\/TH10-07-0460.","journal-title":"Thromb Haemost"},{"issue":"1","key":"key20230905111604_B20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1160\/TH12-05-0332","article-title":"Unfavourable Cardiovascular Disease Risk Profiles in a Cohort of Dutch and British Haemophilia Patients","volume":"109","author":"van de Putte","year":"2013","unstructured":"20. van de Putte DEF, Fischer K, Makris M, Tait RC, Chowdary P, Collins PW, et al. Unfavourable Cardiovascular Disease Risk Profiles in a Cohort of Dutch and British Haemophilia Patients. Thromb Haemost. 2013;109(1):16-23. doi: 10.1160\/TH12-05-0332.","journal-title":"Thromb Haemost"},{"issue":"2","key":"key20230905111604_B21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pop.2014.02.010","article-title":"Screening Strategies for Cardiovascular Disease in Asymptomatic Adults","volume":"41","author":"Wallace","year":"2014","unstructured":"21. Wallace ML, Ricco JA, Barrett B. Screening Strategies for Cardiovascular Disease in Asymptomatic Adults. Prim Care. 2014;41(2):371-97. doi: 10.1016\/j.pop.2014.02.010.","journal-title":"Prim Care"},{"issue":"7","key":"key20230905111604_B22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/eurheartj\/ehy653","article-title":"Equalization of Four Cardiovascular Risk Algorithms after Systematic Recalibration: Individual-Participant Meta-Analysis of 86 Prospective Studies","volume":"40","author":"Pennells","year":"2019","unstructured":"22. Pennells L, Kaptoge S, Wood A, Sweeting M, Zhao X, White I, et al. Equalization of Four Cardiovascular Risk Algorithms after Systematic Recalibration: Individual-Participant Meta-Analysis of 86 Prospective Studies. Eur Heart J. 2019;40(7):621-31. doi: 10.1093\/eurheartj\/ehy653.","journal-title":"Eur Heart J"},{"issue":"3","key":"key20230905111604_B23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/bloodadvances.2021005260","article-title":"Reduced Cardiovascular Morbidity in Patients with Hemophilia: Results of a 5-Year Multinational Prospective Study","volume":"6","author":"van der Valk","year":"2022","unstructured":"23. van der Valk P, Makris M, Fischer K, Tait RC, Chowdary P, Collins PW, et al. Reduced Cardiovascular Morbidity in Patients with Hemophilia: Results of a 5-Year Multinational Prospective Study. Blood Adv. 2022;6(3):902-8. doi: 10.1182\/bloodadvances.2021005260.","journal-title":"Blood Adv"},{"issue":"8","key":"key20230905111604_B24","doi-asserted-by":"crossref","first-page":"JC4","DOI":"10.7326\/0003-4819-157-8-201210160-02012","article-title":"QRISK2-2011 Predicted Cardiovascular Disease in Adult General Practice Patients","volume":"157","author":"Eagle","year":"2012","unstructured":"24. Eagle K, Vaishnava P. ACP Journal Club. QRISK2-2011 Predicted Cardiovascular Disease in Adult General Practice Patients. Ann Intern Med. 2012;157(8):JC4-12. doi: 10.7326\/0003-4819-157-8-201210160-02012.","journal-title":"Ann Intern Med"},{"issue":"12","key":"key20230905111604_B25","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jacc.2009.09.066","article-title":"Screening for Cardiovascular Risk in Asymptomatic Patients","volume":"55","author":"Berger","year":"2010","unstructured":"25. Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS. Screening for Cardiovascular Risk in Asymptomatic Patients. J Am Coll Cardiol. 2010;55(12):1169-77. doi: 10.1016\/j.jacc.2009.09.066.","journal-title":"J Am Coll Cardiol"},{"key":"key20230905111604_B26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/ejh.12498","article-title":"Prevention and Treatment of Atherosclerosis in Haemophilia - How to Balance Risk of Bleeding with Risk of Ischaemic Events","volume":"94","author":"Raucourt","year":"2015","unstructured":"26. Raucourt E, Roussel-Robert V, Zetterberg E. Prevention and Treatment of Atherosclerosis in Haemophilia - How to Balance Risk of Bleeding with Risk of Ischaemic Events. Eur J Haematol. 2015;94(Suppl 77):23-9. doi: 10.1111\/ejh.12498.","journal-title":"Eur J Haematol"},{"issue":"4","key":"key20230905111604_B27","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/bjh.15606","article-title":"Bleeding Risk for Patients with Haemophilia Under Antithrombotic Therapy. Results of the French Multicentric Study ERHEA","volume":"185","author":"Desjonqueres","year":"2019","unstructured":"27. Desjonqueres A, Guillet B, Beurrier P, Pan-Petesch B, Ardillon L, Pineau-Vincent F, et al. Bleeding Risk for Patients with Haemophilia Under Antithrombotic Therapy. Results of the French Multicentric Study ERHEA. Br J Haematol. 2019;185(4):764-7. doi: 10.1111\/bjh.15606.","journal-title":"Br J Haematol"},{"issue":"2","key":"key20230905111604_B28","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","article-title":"Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association","volume":"39","author":"Newman","year":"2019","unstructured":"28. Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL 2nd, Goldstein LB, et al. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association.Arterioscler Thromb Vasc Biol. 2019;39(2):e38-e81. doi: 10.1161\/ATV.0000000000000073.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"key20230905111604_B29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jamacardio.2016.0218","article-title":"Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews","volume":"1","author":"Karmali","year":"2016","unstructured":"29. Karmali KN, Lloyd-Jones DM, Berendsen MA, Goff DC Jr, Sanghavi DM, Brown NC, et al. Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews. JAMA Cardiol. 2016;1(3):341-9. doi: 10.1001\/jamacardio.2016.0218.","journal-title":"JAMA Cardiol"},{"issue":"27","key":"key20230905111604_B30","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/eurheartj\/ehy182","article-title":"Adverse Effects of Statin Therapy: Perception vs. the Evidence - Focus on Glucose Homeostasis, Cognitive, Renal and Hepatic Function, Haemorrhagic Stroke and Cataract","volume":"39","author":"Mach","year":"2018","unstructured":"30. Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, et al. Adverse Effects of Statin Therapy: Perception vs. the Evidence - Focus on Glucose Homeostasis, Cognitive, Renal and Hepatic Function, Haemorrhagic Stroke and Cataract. Eur Heart J. 2018;39(27):2526-39. doi: 10.1093\/eurheartj\/ehy182.","journal-title":"Eur Heart J"},{"issue":"1","key":"key20230905111604_B31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5853\/jos.2016.00864","article-title":"Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update","volume":"19","author":"An","year":"2017","unstructured":"31. An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017;19(1):3-10. doi: 10.5853\/jos.2016.00864.","journal-title":"J Stroke"},{"issue":"1","key":"key20230905111604_B32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2516.2011.02611.x","article-title":"Intracranial Haemorrhage in the Italian Population of Haemophilia Patients with and Without Inhibitors","volume":"18","author":"Zanon","year":"2012","unstructured":"32. Zanon E, Iorio A, Rocino A, Artoni A, Santoro R, Tagliaferri A, et al. Intracranial Haemorrhage in the Italian Population of Haemophilia Patients with and Without Inhibitors. Haemophilia. 2012;18(1):39-45. doi: 10.1111\/j.1365-2516.2011.02611.x.","journal-title":"Haemophilia"},{"issue":"12","key":"key20230905111604_B33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208839","article-title":"Cardiovascular Disease Risk in Patients with Hepatitis C Infection: Results from Two General Population Health Surveys in Canada and the United States (2007-2017)","volume":"13","author":"Badawi","year":"2018","unstructured":"33. Badawi A, Di Giuseppe G, Arora P. Cardiovascular Disease Risk in Patients with Hepatitis C Infection: Results from Two General Population Health Surveys in Canada and the United States (2007-2017). PLoS One. 2018;13(12):e0208839. doi: 10.1371\/journal.pone.0208839.","journal-title":"PLoS One"},{"issue":"3","key":"key20230905111604_B34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.thromres.2014.12.027","article-title":"Prevalence and Risk Factors of Atherothrombotic Events among 1054 Hemophilia Patients: A Population-Based Analysis","volume":"135","author":"Wang","year":"2015","unstructured":"34. Wang JD, Chan WC, Fu YC, Tong KM, Chang ST, Hwang WL, et al. Prevalence and Risk Factors of Atherothrombotic Events among 1054 Hemophilia Patients: A Population-Based Analysis. Thromb Res. 2015;135(3):502-7. doi: 10.1016\/j.thromres.2014.12.027.","journal-title":"Thromb Res"},{"issue":"11","key":"key20230905111604_B35","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/bloodadvances.2018018226","article-title":"A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population","volume":"2","author":"Sood","year":"2018","unstructured":"35. Sood SL, Cheng D, Ragni M, Kessler CM, Quon D, Shapiro AD, et al. A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population. Blood Adv. 2018;2(11):1325-33. doi: 10.1182\/bloodadvances.2018018226.","journal-title":"Blood Adv"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/escores-de-risco-cardiovascular-entre-adultos-assintomaticos-com-hemofilia\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:14:01Z","timestamp":1747401241000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/escores-de-risco-cardiovascular-entre-adultos-assintomaticos-com-hemofilia\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,4]]}},"alternative-id":["10.36660\/abc.20230004"],"URL":"https:\/\/doi.org\/10.36660\/abc.20230004","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"type":"print","value":"0066-782X"},{"type":"electronic","value":"1678-4170"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e20230004"}}